Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
Overview
- Phase
- Phase 4
- Intervention
- Oxycodone
- Conditions
- Hip Arthroscopy
- Sponsor
- Mayo Clinic
- Enrollment
- 188
- Locations
- 1
- Primary Endpoint
- Change in pain score
- Status
- Recruiting
- Last Updated
- 11 months ago
Overview
Brief Summary
This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.
Investigators
Kelechi R. Okoroha
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- •Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN)
Exclusion Criteria
- •medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin.
- •Substantial alcohol or drug abuse.
- •History of narcotics within 6 months of surgery.
- •Pregnancy.
- •Renal impairment.
- •Peptic ulcer disease.
- •GI bleeding.
Arms & Interventions
Standard of Care Group
Subjects will receive standard of care pain medication Oxycodone for pain control following hip arthroscopy procedure
Intervention: Oxycodone
Non-Opiate Pain Control Group
Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.
Intervention: Ibuprofen
Non-Opiate Pain Control Group
Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.
Intervention: Gabapentin
Non-Opiate Pain Control Group
Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.
Intervention: Acetaminophen
Non-Opiate Pain Control Group
Subjects will receive a non-opiate pain control regime using Ibuprofen, Gabapentin, Acetaminophen, Methocarbamol for pain control following hip arthroscopy procedure.
Intervention: Methocarbamol
Outcomes
Primary Outcomes
Change in pain score
Time Frame: Baseline, 14 days post-operatively
Measure using a visual analog scale (VAS) to rate pain on a scale 0-10; 0=no pain to 10=worst possible pain